Chronic obstructive pulmonary disease (COPD) has a significant impact on patients and the
wider health systems. COPD should be managed holistically, and pharmacological …

Sustained bronchodilation using inhaled medications in moderate to severe chronic
obstructive pulmonary disease (COPD) grades 2 and 3 (Global Initiative for Chronic …

Since chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
obstruction, inhaled bronchodilators form the mainstay of treatment. A variety of new inhaled …

Chronic obstructive pulmonary disease (COPD) is a difficult disease to manage, but recent
research focusing on its pathophysiology has provided direction for the development of new …

Chronic obstructive pulmonary disease (COPD) causes significant morbidity and mortality in
the UK. Inhaled therapies are the mainstay of treatment for COPD. The key approaches to …

A variety of inhaler devices are available for delivering treatments to patients with chronic
obstructive pulmonary disease, and new inhalers are currently being developed. Each type …

Chronic obstructive pulmonary disease (COPD) causes around 1 million deaths annually. 1
Guidelines for the diagnosis, management, and prevention of COPD have been published …

The inhaled route is critical for the administration of drugs to treat patients suffering from
COPD, but there is still an unmet need for new and innovative inhalers to address some …

Inhaled therapy for chronic obstructive pulmonary disease can help reduce exacerbation
frequency, admission to hospital and risk of death. Appropriate inhaler choice for the …

COPD is a complex, heterogeneous condition. Even in the early clinical stages, COPD
carries a significant burden, with breathlessness frequently leading to a reduction in …